HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Social Media Marketing Is Indispensable, But Rife With Pitfalls

This article was originally published in The Tan Sheet

Executive Summary

Social media sites like Facebook and Twitter are emerging as invaluable marketing resources for medical device and drug companies, but as FDA develops guidance on the issue companies should be careful to control the content of their Web postings, marketing experts caution

You may also be interested in...



FDA Asks For Industry Input On Regulating Web And New Media Promotion

Drug firms may be one step closer to receiving FDA's guidance on online promotion with the agency's announcement of a public meeting on promoting products via "the Internet and social media tools.

MySpace Too, Says P&G; Social Media Butterfly Creating Buzz Online

Procter & Gamble is blazing the trail for OTC drug and personal care product companies across social networking Web sites like MySpace and YouTube, connecting with consumers on a new level and promoting its brands virally

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS136286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel